Skip to content

EMdoc

Active
Private limited companyfounded 2019active for 7 yearsSiegersveldstraat 32, 3500 Hasselt, BelgiumKBO/BCE: BE 0731.573.802
Summary

EMdoc has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234,627 and a net result of €44,892. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 20% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €250,000turnover 2025, estimated
Equity
€234,627
Profit
€44,892
Turnover estimated from the gross margin
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 21 days early1 of 2 deeds summarised
Why 90raises riskProfit of €44,892 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €1.1mFigures for financial year 2025 (filed 10-07-2026)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 24% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 46-10
equity 20.7% of total assets
Liquidity 66-17
short-term debt 7.8% · cash 13.0%
Profitability 58-26
return on assets 4.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €21,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.01, compared with 5.51 in 2024, above the usual 1.5; short-term debt: 7.8% and cash: 13% of total assets), but 79.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 21% on solvency, 46% on liquidity, 10% on profitability and 19% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 10-07-2026)
NBB · annual accounts
raises risk · Profit of €44,892 (financial year 2025)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 20643 sector peers (2025).
NBB · sector comparison
Position among 20643 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
21 days early
2024
25 days early
2023
13 days early
2022
on the day
2021
18 days late
2020
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 2 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet €44,892 ▼64.7%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Turnover
≈ €250,000
Estimated: probably between €210,000 and €330,000
Total assets
€1.1m▲ 9.7%
2024 · €1.0m
Net result
€44,892▼ 64.7%
2024 · €127,014
Working capital
€89,510▼ 63.3%
2024 · €243,626
Trend over the years

2021 to 2025, 5 financial years 2020 to 2025, 6 financial years

The operating result falls in 2025; 2025 is 53% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.09m 2025 Net result€0.04m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202020212022202320242025
Operating result€0.1m-€0.1m▼ 14.4%€0.1m▼ 22.2%€0.1m▲ 41.7%€0.2m▲ 38.0%€0.09m▼ 53.0%
Net result€0.1mabove the sector's middle half-€0.09mwithin the sector's middle half▼ 13.3%€0.07mwithin the sector's middle half▼ 14.9%€0.09mwithin the sector's middle half▲ 22.9%€0.1mabove the sector's middle half▲ 39.7%€0.04mwithin the sector's middle half▼ 64.7%
Equity€0.1mwithin the sector's middle half-€0.2mwithin the sector's middle half▲ 82.5%€0.3mwithin the sector's middle half▲ 38.4%€0.3mwithin the sector's middle half▲ 8.3%€0.3mwithin the sector's middle half▲ 11.2%€0.2mwithin the sector's middle half▼ 26.1%
Total assets€0.2mwithin the sector's middle half-€0.2mwithin the sector's middle half▲ 22.9%€0.8mabove the sector's middle half▲ 328%€0.9mabove the sector's middle half▲ 0.3%€1.0mabove the sector's middle half▲ 21.6%€1.1mabove the sector's middle half▲ 9.7%
Debt€0.06m-€0.008m▼ 86.5%€0.6m▲ 76×€0.6m▼ 3.4%€0.7m▲ 26.9%€0.9m▲ 25.6%
Working capital€0.1mwithin the sector's middle half-€0.2mwithin the sector's middle half▲ 85.4%€0.2mwithin the sector's middle half▲ 38.3%€0.2mwithin the sector's middle half▼ 0.6%€0.2mwithin the sector's middle half▼ 0.7%€0.09mwithin the sector's middle half▼ 63.3%
Solvency64.7%within the sector's middle half-96.1%above the sector's middle half▲ 31.4pp31.1%below the sector's middle half▼ 65.1pp33.6%below the sector's middle half▲ 2.5pp30.7%below the sector's middle half▼ 2.9pp20.7%below the sector's middle half▼ 10.0pp
Current ratio2.69within the sector's middle half-24.21above the sector's middle half▲ 21.5210.10above the sector's middle half▼ 14.119.65above the sector's middle half▼ 0.455.51within the sector's middle half▼ 4.142.01within the sector's middle half▼ 3.50
Return on assets (ROA)62.1%above the sector's middle half-43.9%above the sector's middle half▼ 18.3pp8.7%within the sector's middle half▼ 35.1pp10.7%within the sector's middle half▲ 2.0pp12.3%within the sector's middle half▲ 1.6pp4.0%below the sector's middle half▼ 8.3pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets €957,956 ▲ 29.9%
Current assets €177,960 ▼ 40.2%
Equity and liabilities €1.1m
Equity €234,627 ▼ 26.1%
Debt €901,288 ▲ 25.6%
Debt's share of the balance-sheet total rises from 69.3% to 79.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€130,698▼
2024 · €219,886
Cash flow
€86,560▼
2024 · €157,300
Debt to equity
3.84▲
2024 · 2.26
ROE
19.1%▼
2024 · 40.0%
Interest coverage
4.14▼
2024 · 8.77
Debt ≤ 1 year
€88,450▲
2024 · €54,029
Debt > 1 year
€812,839▲
2024 · €663,450
Income taxes
€12,575▼
2024 · €37,506
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,372 companies that looked in July 2024 the way this one looks now, 1.9% went bankrupt within 24 months and 96.6% are still going.

  • Small
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
1.9% went bankrupt
1.4% stopped otherwise
96.6% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,372 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.0m€1.1m▲
Fixed assets21/28€0.7m€1.0m▲
Tangible fixed assets22/27€0.7m€1.0m▲
Land and buildings22€0.5m€0.5m▼
Plant, machinery and equipment23€0.03m€0.02m▼
Furniture and vehicles24€0.004m€0.003m▼
Assets under construction and advance payments27€0.2m€0.4m▲
Current assets29/58€0.3m€0.2m▼
Amounts receivable within one year40/41€0.003m€0.005m▲
Trade receivables40-€0.002m
Other amounts receivable41€0.003m€0.003m▼
Cash at bank and in hand54/58€0.3m€0.1m▼
Deferred charges and accrued income490/1€0.03m€0.02m▼
Equity and liabilities
Total equity and liabilities10/49€1.0m€1.1m▲
Equity10/15€0.3m€0.2m▼
Contributions10/11€0.005m€0.005m=
Reserves13€0.3m€0.2m▼
Distributable reserves133€0.3m€0.2m▼
Amounts payable17/49€0.7m€0.9m▲
Amounts payable after more than one year17€0.7m€0.8m▲
Financial debts170/4€0.7m€0.8m▲
Amounts payable within one year42/48€0.05m€0.09m▲
Current portion of amounts payable after more than one year42€0.02m€0.04m▲
Financial debts43€10-
Credit institutions430/8€10-
Trade debts44€0.002m€0.007m▲
Suppliers440/4€0.002m€0.007m▲
Taxes, remuneration and social security45€0.002m€0.008m▲
Taxes450/3€0.002m€0.008m▲
Other amounts payable47/48€0.03m€0.04m▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.03m€0.04m▲
Other operating charges640/8€0.003m€0.003m▲
Gross operating margin9900€0.2m€0.1m▼
Operating profit (loss)9901€0.2m€0.09m▼
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€0.03m€0.03m▲
Recurring financial charges65€0.03m€0.03m▲
Profit (loss) for the period before taxes9903€0.2m€0.06m▼
Income taxes67/77€0.04m€0.01m▼
Profit (loss) for the period9904€0.1m€0.04m▼
Profit (loss) for the period to be appropriated9905€0.1m€0.04m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.1m€0.04m▼
Transfer from equity791/2€0.1m€0.1m▲
Transfer to equity691/2€0.1m€0.04m▼
To other reserves6921€0.1m€0.04m▼
Profit to be distributed694/7€0.1m€0.1m▲
Return on contributions (dividend)694€0.1m€0.1m▲

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,265€2,747€6,084€28,049€30,286€41,668▲ 37.6%
Other operating charges640/8-€209€69,534€1,788€2,619€2,828▲ 8.0%
Gross operating margin9900€149,345€127,633€172,603€167,222€222,506€133,526▼ 40.0%
Operating profit (loss)9901€145,573€124,677€96,985€137,384€189,600€89,031▼ 53.0%
Financial income75/76B-€11€184€1,142€0€0▼ 76.7%
Recurring financial income75-€11€184€1,142€0€0▼ 76.7%
Financial charges65/66B-€2,244€3,320€21,905€25,081€31,563▲ 25.8%
Recurring financial charges65€200€2,244€3,320€21,905€25,081€31,563▲ 25.8%
Profit (loss) for the period before taxes9903€145,373€122,444€93,849€116,622€164,520€57,467▼ 65.1%
Income taxes67/77€45,142€35,507€19,873€25,684€37,506€12,575▼ 66.5%
Profit (loss) for the period9904€100,231€86,937€73,976€90,937€127,014€44,892▼ 64.7%
Profit (loss) for the period to be appropriated9905€100,231€86,937€73,976€90,937€127,014€44,892▼ 64.7%
Line202020212022202320242025Change
Assets
Total assets20/58€0.2m€0.2m€0.8m€0.9m€1.0m€1.1m▲ 9.7%
Fixed assets21/28€0.008m€0.01m€0.6m€0.6m€0.7m€1.0m▲ 29.9%
Tangible fixed assets22/27€0.008m€0.01m€0.6m€0.6m€0.7m€1.0m▲ 29.9%
Land and buildings22-€0.001m€0.6m€0.5m€0.5m€0.5m▼ 4.5%
Plant, machinery and equipment23-€0.001m€0.001m€0.01m€0.03m€0.02m▼ 17.1%
Furniture and vehicles24-€0.01m€0.008m€0.007m€0.004m€0.003m▼ 8.1%
Assets under construction and advance payments27---€0.01m€0.2m€0.4m▲ 134%
Current assets29/58€0.2m€0.2m€0.3m€0.3m€0.3m€0.2m▼ 40.2%
Amounts receivable after more than one year29---€0.04m---
Trade receivables290---€0.04m---
Amounts receivable within one year40/41€0.001m-€0.04m€0.004m€0.003m€0.005m▲ 81.1%
Trade receivables40-----€0.002m-
Other amounts receivable41--€0.04m€0.004m€0.003m€0.003m▼ 2.5%
Cash at bank and in hand54/58€0.1m€0.2m€0.2m€0.2m€0.3m€0.1m▼ 45.1%
Deferred charges and accrued income490/1-€0.002m€0.009m€0.01m€0.03m€0.02m▼ 0.7%
Equity and liabilities
Total equity and liabilities10/49€0.2m€0.2m€0.8m€0.9m€1.0m€1.1m▲ 9.7%
Equity10/15€0.1m€0.2m€0.3m€0.3m€0.3m€0.2m▼ 26.1%
Contributions10/11-€0.005m€0.005m€0.005m€0.005m€0.005m=
Reserves13€0.1m€0.2m€0.3m€0.3m€0.3m€0.2m▼ 26.6%
Distributable reserves133-€0.2m€0.3m€0.3m€0.3m€0.2m▼ 26.6%
Amounts payable17/49€0.06m€0.008m€0.6m€0.6m€0.7m€0.9m▲ 25.6%
Amounts payable after more than one year17--€0.6m€0.5m€0.7m€0.8m▲ 22.5%
Financial debts170/4--€0.6m€0.5m€0.7m€0.8m▲ 22.5%
Amounts payable within one year42/48€0.06m€0.008m€0.03m€0.03m€0.05m€0.09m▲ 63.7%
Current portion of amounts payable after more than one year42--€0.02m€0.02m€0.02m€0.04m▲ 75.0%
Financial debts43-€10€0.002m-€10--
Credit institutions430/8-€10€0.002m-€10--
Trade debts44€0.01m€0.002m€0.004m€0.005m€0.002m€0.007m▲ 283%
Suppliers440/4-€0.002m€0.004m€0.005m€0.002m€0.007m▲ 283%
Taxes, remuneration and social security45-€0.004m€240€0.002m€0.002m€0.008m▲ 229%
Taxes450/3-€0.004m€240€0.002m€0.002m€0.008m▲ 229%
Other amounts payable47/48-€0.001m€0.001m-€0.03m€0.04m▲ 27.8%
Line202020212022202320242025Change
Profit (loss) for the period9904€100,231€86,937€73,976€90,937€127,014€44,892▼ 64.7%
+ Depreciation and write-downs630€2,265€2,747€6,084€28,049€30,286€41,668▲ 37.6%
Operating cash flow (approximation)€102,496€89,684€80,060€118,987€157,300€86,560▼ 45.0%
Investment in fixed assets (approximation)--€6,712-€569,156-€30,461-€190,117-€262,105▼ 37.9%
Change in cash-€34,921€44,309-€4,579€46,454-€121,739-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (6)
Financial year Type Filed Reference
31-12-2025 micro format 10-07-2026 2026-00278584
31-12-2024 micro format 06-07-2025 2025-00234587
31-12-2023 micro format 18-07-2024 2024-00256947
31-12-2022 micro format 31-07-2023 2023-00296601
31-12-2021 micro format 18-08-2022 2022-20313960
31-12-2020 micro format 31-08-2021 2021-60700592

Similar companies · same sector, comparable size

Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,122. 6,711 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2023 · 1 entry · €780 awarded · €3,780 paid
Schemes
1 entry · €780 · €3,780 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 25 July 2019, EMdoc was incorporated as a private limited company.1 The name was changed to EMdoc in 2023.2 In 2023 the registered office moved to Hasselt.2 Total assets went from €161,329 in 2020 to €1.1m in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 02-06-2023
  3. 3National Bank, annual accounts 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
10-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Weakest financial yearnet €44,892 ▼64.7%
Net result drops to €44,892, the lowest in the series.
06-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2020 to 2025net €127,014 ▲39.7%
Operating result €189,600, net result €127,014, both a record.
18-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-07
NBB filing Annual accounts filed
financial year 2022 · micro format
02-06
Gazette deed Registered office · Name
Purpose change · Name change · Amendment of the articles6 facts ▸
  • Other provision, “vrijstelling voorlezing bestuursorgaanverslag, voorzitter ontslagen van voorlezing” (deed in Dutch)
  • Purpose change
  • Name change, EMdoc
  • Amendment of the articles
  • Registered-office move, 3500 Hasselt (Sint-Lambrechts-Herk), Siegersveldstraat 32
  • Other provision, “voorgaande besluiten, stemming besluiten” (deed in Dutch)
2022
31-12
Financial Equity above €200,000equity €263,743 ▲38.4%
A profit in every financial year since 2020 builds equity to €263,743.
18-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 18 days late
2021
31-12
Financial Liquidity more than 8 timescurrent ratio 24.21
Current ratio from 2.69 to 24.21; short-term debt falls from €56,899 to €7,686.
31-12
Financial Equity above €150,000equity €190,568 ▲82.5%
A profit in every financial year since 2020 builds equity to €190,568.
31-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded25-07-2019
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0731573802
Also 9925:BE0731573802
Registered 31-03-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

6488S32EK396QF43AS70
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2019
registered office establishment The establishment unit on the map
Ground area
3,742 m²
Building footprint
386 m²
Building volume
1,805 m³
Parcel 71052D0045/00K000, Flanders · tallest building 14.3 m. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
Dr. Jan Breuls, Urgentiearts
Siegersveldstraat 32, 3500 HasseltSpecialist medical practice
since 2019unit no. 2.307.311.680
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
71052D0045/00K000 Flanders 3,742 m² 1 · 386 m² 14.3 m · 1
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

Name clauseThe name the company operates under according to its articles.
EMdoc
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaamse Gewest, bij enkel besluit bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren in België of…” (deed in Dutch)

deed of 02-06-2023

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Bestuursorgaan, Artikel 10” (deed in Dutch)

deed of 02-06-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Op naam, register van aandelen op naam met vermeldingen voorgeschreven door Wetboek van vennootschappen en verenigingen” (deed in Dutch)

deed of 02-06-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Last Monday of June at 18:00

deed of 02-06-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

2 more provisions in the deed, see the deed of 02-06-2023

deed of 02-06-2023